Retrospective cohort study for assessment of association between imaging changes and outcome after treatment of regorafenib(KSCC1603)

ABSTRACT: Primary outcome(s): We evaluate the radiological changes in pulmonary and hepatic metastatic lesion using CT images scanned within 28 days before regorafenib administration and from 8 weeks to 12 weeks after the administration, and investigate the correlation with prognosis (PFS, OF).

DISEASE(S): Colorectal Cancer

PROVIDER: 2638582 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR